COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A P13K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
- 专利权人:
- NOVARTIS AG
- 发明人:
- KIM, SUNKYU,DOSHI, SHIVANG,HAAS, KRISTY,KOVATS, STEVEN,HUANG, ALAN XIZHONG,CHEN, YEN
- 申请号:
- MYPI 2013004386
- 公开号:
- MY161237A
- 申请日:
- 2012.07.02
- 申请国别(地区):
- MY
- 年份:
- 2017
- 代理人:
- 摘要:
- A COMBINATION OF A CDK4/6 INHIBITOR AND A P3KINASE INHIBITOR FOR THE TREATMENT OF CANCER.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
- combination therapy comprising a cdk4 / 6 inhibitor and a pi3k inhibitor for use in cancer treatment
- COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
- Combination Therapy Comprising A CDK4/6 Inhibitor and a P13K Inhibitor for Use in the Treatment of Cancer
- Combination Therapy Comprising A CDK4/6 Inhibitor and a PI3K Inhibitor for Use in the Treatment of Cancer